Collaboration to develop coronavirus multiplex serological assay

Collaboration to develop coronavirus multiplex serological assay

“We are extremely pleased with the performance of the Sinommune array product and believe this platform will serve as a foundational tool for serological studies in the global fight against COVID-19,” said Dr. Philip Felgner, Director of the Vaccine R&C Center at UCI Medical School. “In order for communities around the globe to understand the prevalence and threat posed by COVID-19, a comprehensive serosurveillance program is necessary to provide policy makers, researchers, and front-line medical professionals with the data necessary to forecast and respond to this fast-moving and dynamic threat.”